These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 29110180

  • 1. Correlation between the molecular effects of mutations at the dimer interface of alanine-glyoxylate aminotransferase leading to primary hyperoxaluria type I and the cellular response to vitamin B6.
    Dindo M, Oppici E, Dell'Orco D, Montone R, Cellini B.
    J Inherit Metab Dis; 2018 Mar; 41(2):263-275. PubMed ID: 29110180
    [Abstract] [Full Text] [Related]

  • 2. Gly161 mutations associated with Primary Hyperoxaluria Type I induce the cytosolic aggregation and the intracellular degradation of the apo-form of alanine:glyoxylate aminotransferase.
    Oppici E, Roncador A, Montioli R, Bianconi S, Cellini B.
    Biochim Biophys Acta; 2013 Dec; 1832(12):2277-88. PubMed ID: 24055001
    [Abstract] [Full Text] [Related]

  • 3. Pyridoxamine and pyridoxal are more effective than pyridoxine in rescuing folding-defective variants of human alanine:glyoxylate aminotransferase causing primary hyperoxaluria type I.
    Oppici E, Fargue S, Reid ES, Mills PB, Clayton PT, Danpure CJ, Cellini B.
    Hum Mol Genet; 2015 Oct 01; 24(19):5500-11. PubMed ID: 26199318
    [Abstract] [Full Text] [Related]

  • 4. The ILE56 mutation on different genetic backgrounds of alanine:glyoxylate aminotransferase: Clinical features and biochemical characterization.
    Dindo M, Mandrile G, Conter C, Montone R, Giachino D, Pelle A, Costantini C, Cellini B.
    Mol Genet Metab; 2020 Oct 01; 131(1-2):171-180. PubMed ID: 32792227
    [Abstract] [Full Text] [Related]

  • 5. Cycloserine enantiomers are reversible inhibitors of human alanine:glyoxylate aminotransferase: implications for Primary Hyperoxaluria type 1.
    Dindo M, Grottelli S, Annunziato G, Giardina G, Pieroni M, Pampalone G, Faccini A, Cutruzzolà F, Laurino P, Costantino G, Cellini B.
    Biochem J; 2019 Dec 23; 476(24):3751-3768. PubMed ID: 31794008
    [Abstract] [Full Text] [Related]

  • 6. Biochemical and cellular effects of a novel missense mutation of the AGXT gene associated with Primary Hyperoxaluria Type 1.
    Gatticchi L, Dindo M, Pampalone G, Conter C, Cellini B, Takayama T.
    Biochem Biophys Res Commun; 2023 Feb 19; 645():118-123. PubMed ID: 36682331
    [Abstract] [Full Text] [Related]

  • 7. Biochemical analyses are instrumental in identifying the impact of mutations on holo and/or apo-forms and on the region(s) of alanine:glyoxylate aminotransferase variants associated with primary hyperoxaluria type I.
    Oppici E, Montioli R, Lorenzetto A, Bianconi S, Borri Voltattorni C, Cellini B.
    Mol Genet Metab; 2012 Jan 19; 105(1):132-40. PubMed ID: 22018727
    [Abstract] [Full Text] [Related]

  • 8. Multiple mechanisms of action of pyridoxine in primary hyperoxaluria type 1.
    Fargue S, Rumsby G, Danpure CJ.
    Biochim Biophys Acta; 2013 Oct 19; 1832(10):1776-83. PubMed ID: 23597595
    [Abstract] [Full Text] [Related]

  • 9. Effects of alanine:glyoxylate aminotransferase variants and pyridoxine sensitivity on oxalate metabolism in a cell-based cytotoxicity assay.
    Fargue S, Knight J, Holmes RP, Rumsby G, Danpure CJ.
    Biochim Biophys Acta; 2016 Jun 19; 1862(6):1055-62. PubMed ID: 26854734
    [Abstract] [Full Text] [Related]

  • 10. Molecular insights into primary hyperoxaluria type 1 pathogenesis.
    Cellini B, Oppici E, Paiardini A, Montioli R.
    Front Biosci (Landmark Ed); 2012 Jan 01; 17(2):621-34. PubMed ID: 22201765
    [Abstract] [Full Text] [Related]

  • 11. Liver peroxisomal alanine:glyoxylate aminotransferase and the effects of mutations associated with Primary Hyperoxaluria Type I: An overview.
    Oppici E, Montioli R, Cellini B.
    Biochim Biophys Acta; 2015 Sep 01; 1854(9):1212-9. PubMed ID: 25620715
    [Abstract] [Full Text] [Related]

  • 12. Misfolding caused by the pathogenic mutation G47R on the minor allele of alanine:glyoxylate aminotransferase and chaperoning activity of pyridoxine.
    Montioli R, Oppici E, Dindo M, Roncador A, Gotte G, Cellini B, Borri Voltattorni C.
    Biochim Biophys Acta; 2015 Oct 01; 1854(10 Pt A):1280-9. PubMed ID: 26149463
    [Abstract] [Full Text] [Related]

  • 13. Natural and Unnatural Compounds Rescue Folding Defects of Human Alanine: Glyoxylate Aminotransferase Leading to Primary Hyperoxaluria Type I.
    Oppici E, Montioli R, Dindo M, Cellini B.
    Curr Drug Targets; 2016 Oct 01; 17(13):1482-91. PubMed ID: 26931357
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of human alanine:glyoxylate aminotransferase in Escherichia coli: renaturation from guanidine-HCl and affinity for pyridoxal phosphate co-factor.
    Coulter-Mackie MB, Lian Q, Wong SG.
    Protein Expr Purif; 2005 May 01; 41(1):18-26. PubMed ID: 15802217
    [Abstract] [Full Text] [Related]

  • 15. Use of polymer conjugates for the intraperoxisomal delivery of engineered human alanine:glyoxylate aminotransferase as a protein therapy for primary hyperoxaluria type I.
    Roncador A, Oppici E, Talelli M, Pariente AN, Donini M, Dusi S, Voltattorni CB, Vicent MJ, Cellini B.
    Nanomedicine; 2017 Apr 01; 13(3):897-907. PubMed ID: 27993722
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Crystal structure of the S187F variant of human liver alanine: glyoxylate [corrected] aminotransferase associated with primary hyperoxaluria type I and its functional implications.
    Oppici E, Fodor K, Paiardini A, Williams C, Voltattorni CB, Wilmanns M, Cellini B.
    Proteins; 2013 Aug 01; 81(8):1457-65. PubMed ID: 23589421
    [Abstract] [Full Text] [Related]

  • 18. Effects of interface mutations on the dimerization of alanine glyoxylate aminotransferase and implications in the mistargeting of the pathogenic variants F152I and I244T.
    Dindo M, Montioli R, Busato M, Giorgetti A, Cellini B, Borri Voltattorni C.
    Biochimie; 2016 Dec 01; 131():137-148. PubMed ID: 27720751
    [Abstract] [Full Text] [Related]

  • 19. Allele-specific characterization of alanine: glyoxylate aminotransferase variants associated with primary hyperoxaluria.
    Lage MD, Pittman AM, Roncador A, Cellini B, Tucker CL.
    PLoS One; 2014 Dec 01; 9(4):e94338. PubMed ID: 24718375
    [Abstract] [Full Text] [Related]

  • 20. The molecular basis of alanine: glyoxylate aminotransferase mistargeting: the most common single cause of primary hyperoxaluria type 1.
    Danpure CJ.
    J Nephrol; 1998 Dec 01; 11 Suppl 1():8-12. PubMed ID: 9604801
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.